Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Ahmed Karam Helmy

Clinical trials sponsored by Ahmed Karam Helmy, explained in plain language.

Not yet recruiting 1

Tracking survival in advanced liver cancer patients on new immune drugs

Disease control Not yet recruiting

This study aims to track how well patients with advanced liver cancer do while receiving immune checkpoint inhibitor drugs as part of their regular treatment. Researchers will follow 75 patients to measure how long they live and how long the cancer stays controlled, while also mo…

Sponsor: Ahmed Karam Helmy • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC